[1]
“Evaluation of the effectiveness of platinum-based chemotherapy in ovarian cancer patients carriers of mutations in BRCA1/2”, Вопр. онкол., vol. 60, no. 3, pp. 339–342, Dec. 2014, doi: 10.37469/0507-3758-2014-60-3-339-342.